Recent News

• 04.08.2025 - Stifel 2025 Virtual Targeted Oncology Forum
• 04.08.2025 - Stifel 2025 Virtual Targeted Oncology Forum
• 04.07.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.07.2025 - 24th Annual Needham Virtual Healthcare Conference
• 03.31.2025 - Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
• 03.31.2025 - Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
• 03.19.2025 - Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
• 03.19.2025 - Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
• 03.06.2025 - Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
• 03.06.2025 - Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Recent Filings

• 03.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.21.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.19.2025 - 8-K Current report
• 03.19.2025 - EX-99.1 EX-99.1
• 03.06.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.06.2025 - 8-K Current report